Lista de obras - Ali Rihani - Dominio Público Uruguay

17q24.2 microdeletions: a new syndromal entity with intellectual disability, truncal obesity, mood swings and hallucinations

artículo científico publicado en 2011

An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours.

artículo científico publicado en 2010

Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.

artículo científico publicado en 2009

CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients

artículo científico publicado en 2014

Cost-effective and robust genotyping using double-mismatch allele-specific quantitative PCR

artículo científico publicado en 2019

Effective Alu repeat based RT-Qpcr normalization in cancer cell perturbation experiments

artículo científico publicado en 2013

Escape from p53-mediated tumor surveillance in neuroblastoma: switching off the p14(ARF)-MDM2-p53 axis.

artículo científico publicado en 2009

Expressed repetitive elements are broadly applicable reference targets for normalization of reverse transcription-qPCR data in mice.

artículo científico publicado en 2018

Functional analysis of the p53 pathway in neuroblastoma cells using the small-molecule MDM2 antagonist nutlin-3.

artículo científico publicado en 2011

Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma

artículo científico publicado en 2015

Inhibition of CDK4/6 as a novel therapeutic option for neuroblastoma.

artículo científico publicado en 2015

Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma.

artículo científico publicado en 2014

Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer

artículo científico publicado en 2013

The need for transparency and good practices in the qPCR literature.

artículo científico publicado en 2013

Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer Compounds

artículo científico publicado en 2020

miRBase Tracker: keeping track of microRNA annotation changes.

artículo científico publicado en 2014

Lista de obras de Ali Rihani

17q24.2 microdeletions: a new syndromal entity with intellectual disability, truncal obesity, mood swings and hallucinations

An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours.

Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.

CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients

Cost-effective and robust genotyping using double-mismatch allele-specific quantitative PCR

Effective Alu repeat based RT-Qpcr normalization in cancer cell perturbation experiments

Escape from p53-mediated tumor surveillance in neuroblastoma: switching off the p14(ARF)-MDM2-p53 axis.

Expressed repetitive elements are broadly applicable reference targets for normalization of reverse transcription-qPCR data in mice.

Functional analysis of the p53 pathway in neuroblastoma cells using the small-molecule MDM2 antagonist nutlin-3.

Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma

Inhibition of CDK4/6 as a novel therapeutic option for neuroblastoma.

Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma.

Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer

The need for transparency and good practices in the qPCR literature.

Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer Compounds

miRBase Tracker: keeping track of microRNA annotation changes.